This study further strengthens the case for using GLP-1 agonists in obese patients with HFpEF, a type of heart failure that is associated with significant morbidity and mortality, said Pooja Prasad, MD, an assistant clinical professor in the Department of Advanced Heart Failure & Transplant Cardiology at the University of California San Francisco
She first tried metformin, a common type 2 diabetes medication, but it wasnt effective for her
As obesity is a major risk factor for various health complications, the introduction of Tirzepatide represents a significant advancement in the treatment landscape for individuals struggling with both diabetes and obesity
When it's more erect, not only are you giving her more pleasure, youre getting more pleasure too, because the more blood flow there is, the more sensation
Pharmacy Direct-to-consumer drug programs: What producers should know June 11, 2026 Cash-pay drug programs may improve access, but they can affect coverage, member costs, and employer visibility
commissioner of Food and Drugs the head of the FDA
